US experts are expected to recommend COVID-19 vaccine boosters after 8 months

Related video above: Pfizer Booster Shot Causes Similar Effects on Second Dose Experts are expected to recommend COVID-19 vaccine enhancers to all Americans, regardless of age, eight months after receiving their second dose of the shot, to ensure lasting protection against coronavirus, as the delta variant spreads across the country. actively looked at whether extra shots for the vaccinated would be needed as early as the fall, reviewed case numbers in the U.S. as well as the situation in other countries like Israel, where preliminary studies suggest the vaccine’s protection against serious illness fell among those vaccinated in January. A statement on the US booster recommendation was expected as soon as this week, according to two people who knew about the case and who spoke to the Associated Press on condition of anonymity to discuss internal considerations. Doses would only begin to be administered widely when the Food and Drug Administration formally approves the vaccines. This action is expected for Pfizer shots in the coming weeks. Last week, U.S. health officials recommended boosters to some with weakened immune systems, citing their higher risk of catching the virus and evidence that vaccines’ effectiveness declined over time. The director of the National Collaboration of Health, Dr. Francis Collins, said Sunday that over the next few weeks, the United States may decide whether to offer coronavirus booster shots to Americans this fall. Among the first to receive them may be health care workers, nursing home residents and other elderly Americans, who were some of the first Americans to be vaccinated when the shots received an emergency permit last December. Since then, more than 198 million Americans have received at least one dose of a COVID-19 vaccine, according to the Centers for Disease Control and Prevention, with more than 168 million fully vaccinated. Nevertheless, the country is experiencing a fourth increase in virus cases due to the more transmissible delta variant, which spreads aggressively through unvaccinated communities, but is also responsible for an increasing number of so-called “breakthrough infections” of fully vaccinated people. Israel, which exclusively administered the Pfizer shot, has offered a coronavirus booster to people over 60 who had already been vaccinated more than five months ago in an attempt to control its own increase in cases from the delta variant. For months, officials had said data still indicated that humans remain highly protected against COVID-19, including the delta variant, after receiving the two-dose Pfizer or Moderna regimen or the one-shot Johnson & Johnson vaccine. But U.S. health officials made it clear Sunday that they are preparing for the possibility that the time for boosters may come sooner rather than later. “There is a concern that the vaccine may begin to decline in its effectiveness,” Collins said. “And delta is an ugly for us to try to deal with. The combination of these two means that we may need boosters, perhaps first with healthcare providers as well as in nursing homes, and then gradually moving forward ”with others, e.g. Elderly Americans who were among the first to receive vaccinations. He said that because the delta variant only began to hit the United States hard in July, the “next few weeks” of case data will help the United States make a decision. The United States in late February to decide when to recommend boosters, one official said. The White House has said that although the United States has begun sharing more than 110 million doses of vaccine with the world, the nation has enough domestic supplies to supply boosters to Americans if they were recommended by health officials. Global health officials, including the World Health Organization, have called on richer and more vaccinated countries to stop booster shots for the safe delivery of first doses to people in developing countries.

Related video above: Pfizer Booster Shot causes similar effects on second dose

U.S. experts are expected to recommend COVID-19 vaccine enhancers to all Americans, regardless of age, eight months after receiving their second dose of the shot, to ensure lasting protection against coronavirus as the delta variant spreads across the country.

Federal health officials have been actively looking at whether extra shots for the vaccinated would be needed as early as this fall, reviewing case numbers in the US as well as the situation in other countries such as Israel, where preliminary studies suggest the vaccine’s protection against serious illness fell among those vaccinated in January.

A statement on the US booster recommendation was expected as soon as this week, according to two people who knew about the case and who spoke to The Associated Press on condition of anonymity to discuss internal considerations.

Doses would only begin to be widely administered once the Food and Drug Administration formally approved the vaccines. This action is expected for the Pfizer shot in the coming weeks.

Last week, U.S. health officials recommended boosters to some with weakened immune systems, citing their higher risk of catching the virus and signs that vaccines’ effectiveness was declining over time.

The director of the National Institutes of Health, Dr. Francis Collins, said Sunday that the United States may decide over the next few weeks whether to offer coronavirus booster shots to Americans this fall.

Among the first to receive them could be health care workers, nursing home residents and other elderly Americans, who were some of the first Americans to be vaccinated when the shots received an emergency permit last December.

Since then, more than 198 million Americans have received at least one dose of a COVID-19 vaccine, according to the Centers for Disease Control and Prevention, with more than 168 million fully vaccinated. Nevertheless, the country is experiencing a fourth increase in virus cases due to the more transmissible delta variant, which spreads aggressively through unvaccinated communities, but is also responsible for an increasing number of so-called “breakthrough infections” of fully vaccinated people.

Israel, which exclusively administered the Pfizer shot, has offered a coronavirus booster to people over 60 who were already vaccinated more than five months ago in an attempt to control its own increase in cases from the delta variant.

For several months, officials had said data still indicated that humans are still heavily protected against COVID-19, including the delta variant, after receiving the two-dose Pfizer or Moderna regimen or the one-shot Johnson & Johnson vaccine. But U.S. health officials made it clear Sunday that they are preparing for the possibility that the time for boosters may come sooner rather than later.

“There is a concern that the vaccine may begin to decline in its effectiveness,” Collins said. “And delta is an ugly for us to try to deal with. The combination of these two means that we may need boosters, perhaps first with healthcare providers as well as in nursing homes, and then gradually moving forward ”with others, e.g. Elderly Americans who were among the first to receive vaccinations.

He said that because the delta variant only began to hit the United States hard in July, the “next few weeks” of case data will help the United States make a decision.

Officials also continued to gather information about the J&J vaccine, which was first approved in the United States in late February, to determine when to recommend boosters, one official said.

The White House has said that even though the United States has begun sharing more than 110 million vaccine doses with the world, the nation has enough domestic supplies to supply boosters to Americans if they are recommended by health officials.

Global health officials, including the World Health Organization, have called on richer and more vaccinated countries to stop booster shots to ensure the delivery of first doses to people in developing countries.

.

Leave a Comment

x